Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Volume 76, Issue 1, Pages 64-73
Publisher
Informa UK Limited
Online
2015-11-07
DOI
10.3109/00365513.2015.1099722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment
- (2015) Ulrick Espelund et al. GROWTH HORMONE & IGF RESEARCH
- Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- (2015) Oscar W.H. Yeung et al. JOURNAL OF HEPATOLOGY
- Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C
- (2014) Konstantin Kazankov et al. HEPATOLOGY
- Vitamin B12and its binding proteins in hepatocellular carcinoma and chronic liver diseases
- (2014) Kira Simonsen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Hepatic macrophage activation predicts clinical decompensation in chronic liver disease
- (2013) Anthony Rode et al. GUT
- Signal regulatory protein α is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression
- (2013) Yu-fei Pan et al. HEPATOLOGY
- Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Tumor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular Carcinoma
- (2013) Yohei Mano et al. PATHOBIOLOGY
- The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
- (2013) Ling-Qun Kong et al. PLoS One
- Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
- (2012) H. Grønbaek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
- (2011) P. Holland-Fischer et al. GUT
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
- (2011) Ken Shirabe et al. SURGERY TODAY
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
- (2009) Jia Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
- (2008) Tong Ding et al. HUMAN PATHOLOGY
- Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection
- (2008) Yi-Wei Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search